VGVittorio Giusti

Vittorio Giusti

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Vittorio Giusti has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Michel Suter

    Department of Surgery, d Institute of Social and Preventive Medicine University Hospital CHUV Lausanne Switzerland

    4 shared publications
  • Chantal Verdumo

    Service of Endocrinology, Diabetes and Metabolism

    2 shared publications
  • A. Paroz

    Department of Surgery, University Hospital CHUV, Lausanne, Switzerland

    1 shared publication
  • Alexandre Paroz

    Department of Surgery, d Institute of Social and Preventive Medicine University Hospital CHUV Lausanne Switzerland

    1 shared publication
  • C. Darimont

    Nestlé Research Center, Vers‐Chez‐Les‐Blanc, Lausanne 26, Switzerland

    1 shared publication
  • C. Leyvraz

    Service of Endocrinology, Diabetology and Metabolism, University Hospital CHUV, Lausanne, Switzerland

    1 shared publication

Latest Publications

  • Open Access

    Bariatric surgery in an obese patient with Albright hereditary osteodystrophy: a case report

    by Chiara Ferrario, Giacomo Gastaldi, Luc Portmann, Vittorio Giusti

    We report for the first time the case of a patient with Albright hereditary osteodystrophy and pseudopseudohypoparathyroidism who underwent a Roux-en-Y gastric bypass. A 26-year-old obese Caucasian woman with Albright hereditary osteodystrophy with pseudopseudohypoparathyroidism (heterozygous mutation (L272F) in GNAS1 exon 10 on molecular analysis) was treated with gastric bypass. She had the classical features of Albright hereditary osteodystrophy: short stature (138cm), obesity (body mass index 49.5kg/m2), bilateral shortening of the fourth and fifth metacarpals, short neck, round and wide face with bombed front and small eyes. Before the gastric bypass was performed, biochemical determination revealed a slightly low serum calcium level (2.09mmol/L; normal range 2.1 to 2.5mmol/l), and an elevated parathyroid hormone level (87ng/L; normal range 10 to 70ng/L) associated with low vitamin D level (19μg/L; normal range 30 to 50μg/L). Vitamin D supplementation was prescribed before surgery. After the Roux-en-Y gastric bypass, she achieved a progressive substantial weight loss, from 94kg (body mass index 49.5kg/m2) to 49kg (body mass index 25.9kg/m2) in one year. Her weight then stabilized at 50kg (body mass index 26kg/m2) during our three years of follow-up. Before the operation and every three months after it, she was screened for nutritional deficiencies, and serum markers of bone turnover and renal function were monitored. Considering the deficiencies in zinc, magnesium, calcium, vitamin D and vitamin B12, appropriate supplementation was prescribed. Before and two years after the Roux-en-Y gastric bypass, a dual-energy X-ray absorptiometry assessment of bone density was performed that showed no changes on her lumbar column (0.882g/cm2 and both T-score and Z-score of -1.5 standard deviation). In addition, bone microarchitecture with a measurement of her trabecular bone score was found to be normal. This is the first case of Roux-en-Y gastric bypass described in a patient with pseudopseudohypoparathyroidism showing that such a procedure seems to be safe in obese patients with Albright hereditary osteodystrophy and pseudopseudohypoparathyroidism if appropriately followed up. As obesity is a prominent feature of Albright hereditary osteodystrophy, such patients might seek bariatric surgery. After a Roux-en-Y gastric bypass, patients with Albright hereditary osteodystrophy associated with pseudopseudohypoparathyroidism need long-term follow-up on nutritional and metabolic issues.


    • 27 March 2013
      • Vol. 9  (379) , 658, 660-3

    [Bariatric surgery in 2013: principles, advantages and disadvantages of the available procedures].

    by Michel Suter, Vittorio Giusti

    For severe obesity (BMI > 35 kg/m2), bariatric surgery is not only the best, but often the only means of obtaining sufficient and durable weight loss. This article aims to review the available bariatric procedures. Gastric bypass remains the reference when it comes to the risk/benefit ratio. Gastric banding is declining rapidly due to the high prevalence of long-term complications. Primary malabsorptive procedures remain largely unpopular because of their potential nutritional complications. Sleeve gastrectomy, although it is not reversible as it includes a significant gastric resection, increases currently in popularity because of its apparent simplicity and the fact that early results regarding weight loss mimic those obtained with gastric bypass.


  • Open Access

    Changes in Gene Expression Profile in Human Subcutaneous Adipose Tissue during Significant Weight Loss

    by Céline Leyvraz, Chantal Verdumo, Michel Suter, Alexandre Paroz, Jean-Marie Calmes, Pedro M. Marques-Vidal, Vittorio Giusti

    Objective: To analyze the expression of peroxisome proliferator-activated receptor-γ1 and 2 (PPARγ1 and 2), 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1), and leptin in adipose tissue (AT) of obese women during weight loss following Roux-en-Y gastric bypass (RYGB) and to compare these levels with those obtained in AT of nonobese subjects. Methods: Gene expression was determined by real-time RT-PCR prior to surgery and at 3, 6, and 12 months after RYGB. Results: All obese patients lost weight, reaching a mean BMI of 29.3 ± 1.0 kg/m2 at 1 year after surgery (–33.9 ± 1.5% of their initial body weight). In obese subjects leptin and 11βHSD1 were over-expressed, whereas PPARγ1 was expressed at lower levels compared to controls. After surgery, leptin and 11βHSD1 gene expression decreased, whereas PPARγ1 expression increased. At 12 months after RYGB, these 3 genes had reached levels similar to the controls. In contrast, PPARγ2 gene expression was not different between groups and types of tissue and remained unchanged during weight loss. We found a positive correlation between BMI and levels of gene expression of leptin and 11βHSD1. Conclusion: Gene expression of leptin, PPARγ1, and 11βHSD1 in AT is modified in human obesity. This default is completely corrected by RYGB.


    • 28 March 2012
      • Vol. 8  (334) , 667-8

    [The skid of bariatric surgery: when the amount of risk exceeds the quality].

    by Michel Suter, Vittorio Giusti

    • 30 March 2011
      • Vol. 7  (288) , 700-4

    [New guidelines for bariatric surgery care: practical implications].

    by V Giusti, M Suter

    From the 1st of January 2011, new conditions have been validated in which surgery for weight loss is borne by the basic insurance. These are very significant changes compared to the old criteria. Indeed, on one hand, patients with BMI > or = 35 kg/m2 may, without age limit and in the absence of comorbidities benefit from surgery without prior request to the medical council health insurance company concerned. On the other hand, the notion of a minimum casuistry is for the first time introduced in centers performing this type of intervention. In addition, certified centers are required to follow standard procedures for the patients' teaching and follow up.

    • 30 March 2011
      • Vol. 7  (288) , 711-5

    [Anorexia: somatic assessment and management].

    by V Giusti, S Gebhard

    Anorexia nervosa, which affects about 2-3% of the general population, is the psychiatric illness with the highest rate of mortality. The management is often complex, requiring multiple stakeholders on the patient's physical and psychiatric. The new specialized centre "abC" (anorexia-bulimia, Centre vaudois) was created with the objective of providing quality services to patients involved and to provide a network facilitating the interaction between physicians and specialized institutions. This is an inter-institutional and interdisciplinary collaboration born of the CHUV and the eHnv (Hospitalized Institutions in Nord Vaudois). The abC includes an outpatient pole (CHUV) and a hospital unit on the site of Saint Loup. At term, it will include a day centre (CHUV).


    • 26 January 2011
      • Vol. 7  (279) , 220-1

    [When and how to treat obesity].

    by V Giusti

  • Open Access

    The predictive value of psychological assessment of candidates for gastric bypass: A medical chart review

    by Nathalie Aubert, Isabelle Lyon-Pagès, Isabelle Carrard, Michel Suter, Friedrich Stiefel, Vittorio Giusti

    Background and Objectives: Guidelines for bariatric surgery demand a psychological evaluation of applicants. The aim of this study was to evaluate if the presence of "psychological risk factors" predicts postoperative weight loss after gastric bypass.\ud Methods: Medical records of obese women who underwent bariatric surgery between 2000 and 2004 were reviewed. Psychological assessment consisted of a one-hour semi-structured interview, summarized in a written report. Anthropometric assessment at baseline and 6,12,18 and 24 months after surgery included body weight, height and body mass index.\ud Results: The mean BMI of included patients (N = 92) was 46.2 + 6,3 kg/m2 (range 38.4 - 69.7). Based on the psychological assessment, 27% (N = 25) of the patients were classified as having "psychological risk factors" and 28% (N = 26) were diagnosed with a psychiatric diagnosis, most often major depression. Two years after gastric bypass, 16% of patients with "psychological risk factors" achieved an excellent result (%EWL > 75) versus 39% of those without (p < 0.05). About 1 out of 4 patients was in postoperative psychiatric treatment, but only half of them were identified as having "psychological risk factors" at baseline. Weight loss of patients initiating a psychiatric treatment only after surgery was less than of patients who continued psychiatric treatment already initiated before surgery (55.7 + 14.8 versus 66.5 + 14.2 %EWL).\ud Conclusions: A single semi-structured psychological interview may identify patients who are at risk for diminished postoperative weight loss; however, psychological assessment did not identify those patients who were in need of a psychiatric postoperative treatment


    • 31 March 2010
      • Vol. 6  (242) , 670-4, 676

    [Surgery for diabetes: challenge or reality?].

    by V Giusti

    Bariatric surgery techniques can usually increase either sensitivity or insulin resistance, acting on three different levels: decrease of food intake, malabsorption and modifications of entero-insulaire axis activity. This latter is taken into account in order to develop a new protocol to obtain diabetes remission without important weight loss and nutritional deficiencies. Preliminary results are interesting but they come from very short time studies with few patients. Moreover, complications rate is at present very high. Knowing better gastrointestinal mechanisms of diabetes control and especially incretins role is absolutely necessary before identifying surgery as a true metabolic treatment.

  • Selective effects of PPARγ agonists and antagonists on human pre‐adipocyte differentiation

    by C. Leyvraz, M. Suter, C. Verdumo, J.‐M. Calmes, A. Paroz, C. Darimont, R. C. Gaillard, F. P. Pralong, V. Giusti

    Aim: The insulin sensitizer rosiglitazone (RTZ) acts by activating peroxisome proliferator and activated receptor γ (PPAR γ), an effect accompanied in vivo in humans by an increase in fat storage. We hypothesized that this effect concerns PPARγ 1 and PPARγ 2 differently and is dependant on the origin of the adipose cells (subcutaneous or visceral). To this aim, the effect of RTZ, the PPARγ antagonist GW9662 and lentiviral vectors expressing interfering RNA were evaluated on human pre‐adipocyte models. Methods: Two models were investigated: the human pre‐adipose cell line Chub‐S7 and primary pre‐adipocytes derived from subcutaneous and visceral biopsies of adipose tissue (AT) obtained from obese patients. Cells were used to perform oil‐red O staining, gene expression measurements and lentiviral infections. Results: In both models, RTZ was found to stimulate the differentiation of pre‐adipocytes into mature cells. This was accompanied by significant increases in both the PPARγ 1 and PPARγ 2 gene expression, with a relatively stronger stimulation of PPARγ 2 . In contrast, RTZ failed to stimulate differentiation processes when cells were incubated in the presence of GW9662. This effect was similar to the effect observed using interfering RNA against PPARγ 2 . It was accompanied by an abrogation of the RTZ‐induced PPARγ 2 gene expression, whereas the level of PPARγ 1 was not affected. Conclusions: Both the GW9662 treatment and interfering RNA against PPARγ 2 are able to abrogate RTZ‐induced differentiation without a significant change of PPARγ 1 gene expression. These results are consistent with previous results obtained in animal models and suggest that in humans PPARγ 2 may also be the key isoform involved in fat storage.